Table 2.
Outcomes of OS, PFS, and EFS by lines of therapy.
| 1st-line (n = 922) |
2nd-line (n = 457) |
3rd-line (n = 299) |
4th-line (n = 198) |
5th-line (n = 128) |
6th-line (n = 81) |
|
|---|---|---|---|---|---|---|
| OS | NR (NR-NR) | 11.67 (9.67−NR) | 8.75 (6.84−NR) | 5.34 (3.51−NR) | 3.13 (2.22–6.13) | 1.93 (1.25–5.52) |
| PFS | 4.73 (3.93–5.71) | 1.51 (1.22–1.92) | 1.07 (0.93–1.39) | 0.90 (0.59–1.10) | 0.55 (0.33–0.92) | 0.48 (0.28–0.71) |
| EFS | 3.91 (3.39–4.79) | 1.04 (0.89–1.31) | 0.73 (0.57–0.94) | 0.56 (0.48–0.84) | 0.35 (0.29–0.62) | 0.30 (0.26–0.50) |
Data are median (95% CI) years.
NR not reached.